Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
about
Effective post-exposure treatment of Ebola infectionEbola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.The organisation of Ebola virus reveals a capacity for extensive, modular polyploidyStructural and Functional Characterization of Reston Ebola Virus VP35 Interferon Inhibitory Domain[Haemostasis dysregulation in filovirus infections].Risks Posed by Reston, the Forgotten Ebolavirus.A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity.Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.Characterization of the envelope glycoprotein of a novel filovirus, lloviu virusMetagenomic detection of phage-encoded platelet-binding factors in the human oral cavity.Molecular determinants of Ebola virus virulence in mice.The Baboon (Papio spp.) as a model of human Ebola virus infection.Pathology of experimental Machupo virus infection, Chicava strain, in cynomolgus macaques (Macaca fascicularis) by intramuscular and aerosol exposure.Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation.Different potential of C-type lectin-mediated entry between Marburg virus strainsProtective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever.VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in miceEbolavirus VP35 is a multifunctional virulence factor.Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection.Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells.Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infectionThe role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection.C-type lectins do not act as functional receptors for filovirus entry into cells.The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencingEbola virus exploits a monocyte differentiation program to promote its entryInterferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.Disease modeling for Ebola and Marburg viruses.Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infectionEvasion of interferon responses by Ebola and Marburg viruses.Filovirus entry: a novelty in the viral fusion world.Characterization of host immune responses in Ebola virus infections.Viral proteins that bind double-stranded RNA: countermeasures against host antiviral responses.Molecular pathogenesis of viral hemorrhagic fever.Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.Exploration micromechanism of VP35 IID interaction and recognition dsRNA: A molecular dynamics simulation.[Ebola outbreak in Westafrica].The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR.
P2860
Q21131616-6E5CB858-46E3-484F-8BA8-934D37139AE4Q24318342-A4984657-F935-4D9E-86E1-AD3FF0513AA4Q24568225-7FA37E39-94AB-4F03-B768-3029E6E3AB66Q25256700-7AB063E0-8453-4C24-AFC9-76AA1CE00AE1Q27310373-2F108F82-5956-4106-B2BF-98EB7705E3E4Q27660589-F71AF019-E2BB-4FA3-A3BC-11CA15B990ADQ27691452-9294D5F0-AE8D-44AB-9266-23FD8AC1EBF6Q30239113-3658DD84-5ABF-403E-AEC5-F252C682F2D2Q30279239-124C0CF6-ACB5-441B-8979-E14EE576C135Q30386606-FB6553A6-9380-4799-8A82-78FF53BA19C5Q30391355-0BA4DB8E-D3D0-4455-ABF3-F07674D90A2FQ30499059-D27CA3D9-23F2-423D-81A0-CB10E5BCD0E2Q33250567-92829007-6AFB-43D2-A08A-0B16ABDB7B6CQ33404644-97C08944-68F0-46FC-8404-C6587C0B4A42Q33416246-E1475632-9855-455C-9BB3-0F246931EA27Q33784486-7A111003-740D-4A14-9E13-476CDDC89B1FQ33826885-94E2C476-6786-4120-8940-9FABAE54052EQ34257290-2861E952-F8E8-4D4E-BBC1-F9DC84F82E8EQ34509643-A60EA247-D5B6-4986-BCEB-3DDE942E1D34Q34700463-3E37482E-8B48-414E-BA4D-E78534D56F41Q35193052-2278E374-7B49-423B-9971-0CD2A5DECDC7Q35299800-BDE1C047-4552-4EB7-9056-B0C6BDCF84D3Q35300104-B064AB90-2118-4C01-96F8-FD46C8352981Q35823426-E32A57EE-54B8-4F2E-A7FC-977CFAA6242AQ36043296-B386AAE7-261E-4477-99C7-811E68B4165FQ36085816-EEFD7C0E-7BE0-42EB-9105-713970E8A9EDQ36411422-D2B83D42-B252-4252-B189-E992A12D9F9CQ36759731-CF68AD45-5D5A-4652-9170-720BD1073A6BQ36936330-A909CEF9-8513-419F-A82A-BCD2BA17CEA7Q37040575-6DA94334-D73B-4BFD-8ED0-C2F3F0591227Q37190830-8F365564-9C7A-4CBC-9D40-4F89A94E5CF8Q37582945-C5807F57-DA26-41F5-AFE5-EC401229B0E2Q37999360-F1D3A501-4799-431D-BEB0-CA873097EB10Q38205274-85422344-5A2E-4E06-AEAD-01D01592431CQ38218190-C90AC224-090A-46E5-876D-F8C2F1DBEC97Q39337289-C1095868-D360-4D64-B412-F8E3AB677C99Q39603352-6B63B54E-AE15-4D72-A7C0-C2F1D3CA08C2Q40068731-62CD08D3-0728-4CB7-90CA-F1B9C5E0516EQ40142543-8DA1EDDF-FD1B-4F33-984B-E5139E8C044CQ40267837-684CDF06-EDE2-4007-9C31-6952A158800E
P2860
Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Ebola virus: new insights into ...... ble therapeutic interventions.
@ast
Ebola virus: new insights into ...... ble therapeutic interventions.
@en
type
label
Ebola virus: new insights into ...... ble therapeutic interventions.
@ast
Ebola virus: new insights into ...... ble therapeutic interventions.
@en
prefLabel
Ebola virus: new insights into ...... ble therapeutic interventions.
@ast
Ebola virus: new insights into ...... ble therapeutic interventions.
@en
P1476
Ebola virus: new insights into ...... ble therapeutic interventions.
@en
P356
10.1017/S1462399404008300
P577
2004-09-21T00:00:00Z